Search
Teva Pharmaceutical Industries Ltd
TEVAAdd to Watchlist
35.000USD
-0.410-1.16%
Close 07-31 16:00（ET）Quotes delayed by 15 min
40.77BMarket Cap
28.42P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Teva Pharmaceutical Industries Ltd is 8.67, ranking 12 out of 155 in the Pharmaceuticals industry. The average price target is 29.50, with a high of 35.00 and a low of 18.07.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
38.930
Target Price
+12.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Teva Pharmaceutical Industries Ltd
TEVA
12
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Teva Pharmaceutical Industries Ltd's expected revenue for the next quarter?
Teva Pharmaceutical Industries Ltd's expected revenue is 4.23B.
What is Teva Pharmaceutical Industries Ltd's price target?
Analysts forecast that Teva Pharmaceutical Industries Ltd's price target is USD 29.50, with the highest forecast at USD 35.00 and the lowest forecast at USD 18.07.
How have Teva Pharmaceutical Industries LtdTEVA's recent earnings per share performed?
The market expectation was USD -0.49, while Teva Pharmaceutical Industries LtdTEVA's earnings per share (EPS) for the previous quarter was USD 0.32. EPS for the next quarter is expected at USD 0.65.
What is the analyst rating for Teva Pharmaceutical Industries Ltd?
Based on the ratings of Teva Pharmaceutical Industries Ltd's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.